Standout Papers
Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
2014
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections
2012
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams
2011
Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation
2009
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
2012
Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
2013
Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
2011
Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype
2014
General Principles of Antimicrobial Therapy
2011
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Safety of triazole antifungal drugs in patients with cancer
2009
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Candida in Solid Organ Transplant Recipients
2009
Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients
2012
The structure–function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: The mechanism of L98H azole resistance
2011
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
2013
Candida albicanspathogenicity mechanisms
2013 Standout
Bench-to-bedside review: Candida infections in the intensive care unit
2008
Aspergillus Vertebral Osteomyelitis in Immunocompetent Hosts: Role of Triazole Antifungal Therapy
2010
Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
2014
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
2012
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
2009
Administration of Voriconazole in Patients With Renal Dysfunction
2012
Antifungal agents – clinical pharmacokinetics and drug interactions
2008
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
2012
Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity
2014
Coccidioidal Meningitis
2010
Treatment of Endogenous Fungal Endophthalmitis: Focus on New Antifungal Agents
2011
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Voriconazole concentrations and outcome of invasive fungal infections
2009
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
2012
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Steady-state pharmacokinetics and metabolism of voriconazole in patients
2013
The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant
2015
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
β‐L actam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review
2012
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
2012
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Azole-Based Energetic Salts
2011 Standout
Prevention and Treatment of Cancer-Related Infections
2012
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Antifungal Therapy of Aspergillus Invasive Otitis Externa: Efficacy of Voriconazole and Review
2008
Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population
2013
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults
2011
Invasive Candidiasis
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Software for Dosage Individualization of Voriconazole for Immunocompromised Patients
2013
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Pharmacogenomics of the Triazole Antifungal Agent Voriconazole
2011
Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
2012
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients
2018
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
2009
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
2012
Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy Adults
2011
Works of S. Bolay being referenced
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections
2012
Prospective monitoring of cefepime in intensive care unit adult patients
2010
Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods
2006
High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function
2010